封面
市场调查报告书
商品编码
1935756

咽喉片市场:活性成分、产品形式、口味、价格范围、消费群体和分销管道,全球预测,2026-2032年

Throat Pastilles Market by Active Ingredient, Product Form, Flavor, Price Tier, Consumer Age Group, Distribution Channel - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年,喉糖市场价值将达到 53.9 亿美元,到 2026 年将成长至 58.1 亿美元,到 2032 年将达到 94.5 亿美元,年复合成长率为 8.34%。

关键市场统计数据
基准年 2025 53.9亿美元
预计年份:2026年 58.1亿美元
预测年份 2032 94.5亿美元
复合年增长率 (%) 8.34%

简要概述了当前消费者的购买动机、零售趋势以及塑造现代健康保健市场中润喉醣品类的产品创新。

润喉醣品类正经历变革时期,其驱动力包括消费者日益增强的健康意识、零售模式的演变以及成分的创新。消费者越来越倾向于选择既能缓解症状又能带来健康益处的产品,品牌也积极响应,推出针对性配方、更清晰的成分标籤以及多样化的口味和剂型。因此,润喉醣品类如今既被归类于医药产品,也被归类于更广泛的功能性糖果甜点品类,模糊了传统止咳产品和日常咽喉护理产品之间的界限。

成分透明度、全通路商务的加速发展、监管审查的加强以及对永续性的优先考虑,正在共同重塑润喉醣品类的竞争格局。

润喉糖市场格局正受到多种因素的共同影响而重塑,这些因素正在改变产品开发、分销和消费者互动方式。成分透明度和洁净标示已成为强制性要求,消费者要求成分来源清晰、添加剂极少,并拥有明确且检验的功能性声明。为了满足这些消费者需求,配方师正优先考虑公认的植物成分、经临床验证的活性成分,以及在功效和日常食用性之间取得平衡的低糖或无糖配方。

检验2025 年关税调整对润喉糖製造商和经销商的采购选择、生产地点决策和供应链弹性的影响。

贸易政策调整,包括2025年生效的关税变更,为依赖国际原料采购和成品跨境分销的製造商和经销商带来了新的挑战。某些原材料和包装组件进口关税的提高,增加了依赖特定贸易伙伴原材料的产品的到岸成本,促使采购团队重新评估供应商资格、调整谈判策略并审查库存政策。在许多情况下,製造商采取的应对措施是加快关键原材料的在地采购,或转向贸易条件更有利地区的其他供应商。

策略性细分洞察将活性成分、分销管道、产品形式、口味、价格点和年龄层进行匹配,从而优化产品组合、通讯和分销策略。

精准的市场区隔对于了解消费者偏好、制定产品和分销策略至关重要。根据活性成分,尤加利油、草本混合物、薄荷醇和锌基配方构成了该品类,每种配方都满足不同的消费者需求,例如舒缓、增强免疫力和缓解症状。製造商应根据实际情况调整产品宣称、感官属性和剂型。不同分销管道的产品表现差异显着,便利商店、线上零售商、药局/药局和超级市场/大卖场的销售情况各不相同。线上零售商更倾向于订阅模式和口味创新,而药局则更注重基于临床通讯和货架陈列,以促进消费者基于信任的购买行为。

区域观点揭示了消费者偏好、监管细微差别、零售结构和製造地如何塑造全球市场的润喉糖策略。

区域趋势导緻美洲、欧洲、中东和非洲以及亚太地区的需求模式和业务重点截然不同。在美洲,消费者需求优先考虑便利性、口味多样性以及在药局和超级市场通路的强大零售覆盖,而电子商务则推动了小众口味和订阅服务的快速普及。同时,欧洲、中东和非洲的法规环境多元化,并高度重视天然成分和临床可信度,促使品牌投资于统一的标籤标准和区域性特定的原料采购。

主要企业如何平衡产品创新、全通路部署、供应链敏捷性和策略伙伴关係,以保持领先地位并适应不断变化的市场压力?

为了保持竞争优势,主要企业正致力于产品创新、分销管道多元化和营运效率提升。研发投入的重点在于研发能够将可靠的缓解症状活性成分与植物成分和无糖甜味剂相结合的配方,以在确保疗效的同时兼顾日常健康维护。同时,製造商也在优化包装,以清楚展示剂量说明,提升商店差异化,并探索多种产品形式以满足不同的使用情境。

为经营团队提供实际的策略行动,以加速产品差异化、加强分销合作、提升供应链韧性,同时推动永续发展目标。

产业领导者应采取整合策略,将消费者洞察与营运柔软性结合,以充分利用整个品类的发展动能。首先,加快研发符合洁净标示要求并提供差异化功能性声明的配方,确保所有声明均有临床和科学证据支持。将这些配方优势与引人入胜的感官设计(风味和质地分析)结合,降低试用门槛,提高重购意愿。

结合相关人员访谈、零售观察、监管分析和资料三角验证的严谨混合方法研究途径,确保了可靠的策略指导。

本分析整合了第一手和第二手调查方法,以建立基于证据的观点。第一手研究包括对品类经理、采购主管、零售买手和临床专家进行结构化访谈,以获取有关配方优先顺序、分销渠道经济效益和供应链限制因素的第一手资讯。此外,也对零售门市和电商平台进行了观察性研究,以了解产品陈列、产品可发现性和消费者评价方面的趋势。

最终整合将以消费者主导的配方设计、通路完整性和供应链适应性连结起来,作为喉片市场竞争优势的决定性因素

一项综合分析表明,润喉醣品类兼具功能性功效和日常健康行为。消费者对成分透明、包装便利、健康声明可信的需求正在推动产品和通路创新,而贸易政策和区域监管差异则要求企业采取灵活的采购和合规策略。能够将配方、口味和包装形式与明确的通路策略结合的企业,将更有利于吸引不同消费群体的试用者并建立忠诚度。

目录

第一章:序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵,2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章:美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

8. 依活性成分分類的咽喉片市场

  • 尤加利
  • 草本混合物
  • 薄荷醇

9. 依产品类型分類的咽喉片市场

  • 硬片剂
  • 软咀嚼片
  • 无醣

第十章 依口味分類的咽喉片市场

  • 柠檬
  • 薄荷
  • 混合水果

第十一章 咽喉片市场价格范围

  • 中价位
  • 优质的
  • 价值

第十二章 依消费者年龄层分類的咽喉片市场

  • 成人
  • 孩子们
  • 老年人

第十三章 咽喉片市场(依通路划分)

  • 便利商店
  • 线上零售
  • 药房和药品商店
  • 超级市场和大卖场

第十四章 各地区咽喉片市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 咽喉片剂市场(依组别划分)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国咽喉片市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章:美国咽喉片市场

第十八章:中国咽喉片市场

第十九章 竞争情势

  • 市场集中度分析,2025年
    • 浓度比(CR)
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析,2025 年
  • 2025年产品系列分析
  • 基准分析,2025 年
  • Bliss GVS Pharma Ltd
  • Boiron SA
  • Catalent, Inc. by Novo Holdings A/S
  • Church & Dwight Co., Inc.
  • Cipla Limited
  • Dabur International Limited
  • Doetsch Grether AG
  • Essity AB(publ)
  • Gepach International
  • Haleon plc
  • Kenvue Inc.
  • Lofthouse of Fleetwood Ltd.
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group plc
  • Ricola AG
  • Ricola Group AG
  • Rohto Pharmaceutical Co., Ltd.
Product Code: MRR-9A6A6F297518

The Throat Pastilles Market was valued at USD 5.39 billion in 2025 and is projected to grow to USD 5.81 billion in 2026, with a CAGR of 8.34%, reaching USD 9.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.39 billion
Estimated Year [2026] USD 5.81 billion
Forecast Year [2032] USD 9.45 billion
CAGR (%) 8.34%

A concise orientation to current consumer motivations, retail dynamics, and product innovation shaping the throat pastilles category in contemporary health and wellness markets

The throat pastilles category is experiencing an inflection driven by health-conscious consumers, evolving retail formats, and ingredient innovation. Consumers are increasingly seeking products that combine symptomatic relief with perceived wellness benefits, and brands are responding through targeted formulations, clearer ingredient communication, and diversified flavor and form portfolios. As a result, the category now occupies both the clinical aisle and the broader functional confectionery space, blurring traditional boundaries between cough remedies and everyday throat care.

Retail dynamics have shifted alongside consumer behavior. Online channels and pharmacy shelf prominence have raised expectations for both product information and convenient access, while traditional bricks-and-mortar channels maintain importance for impulse and point-of-care purchases. Product developers are prioritizing experiences that align with sensory preference and daily wellness rituals, resulting in a proliferation of soft chewable formats, sugar-free options, and botanical blends that appeal to multiple age cohorts.

This introduction sets the stage for a focused review of how demand patterns, regulatory developments, trade dynamics, and segmentation strategies are shaping competitive positioning. The subsequent sections synthesize core shifts, regional nuances, and tactical implications to inform product innovation, go-to-market planning, and supply chain resilience for stakeholders across the value chain.

How ingredient transparency, omnichannel commerce acceleration, regulatory scrutiny, and sustainability priorities are jointly redefining competitive dynamics in the throat pastilles sector

The landscape for throat pastilles has been reshaped by several converging forces that are transforming product development, distribution, and consumer engagement. Ingredient transparency and clean-label expectations are now table stakes; consumers demand clear provenance, minimal additives, and functional claims that are straightforward and verifiable. This consumer insistence is prompting formulators to prioritize recognizable botanicals, clinically familiar actives, and reduced-sugar or sugar-free formats that reconcile efficacy with everyday consumption.

Simultaneously, digital commerce and direct-to-consumer experimentation have accelerated product discovery and trial. Online retail has enabled niche and challenger brands to scale rapidly by leveraging targeted digital marketing, subscription models, and consumer reviews to build credibility. At the same time, traditional retail channels are adapting by enhancing in-store education, merchandising throat care across health and wellness adjacencies, and integrating omnichannel capabilities to capture both planned and impulse purchases.

Regulatory scrutiny and trade dynamics are also driving change. Tighter labeling rules and scrutiny of health claims require more robust evidence and clearer consumer communication. Sustainability and packaging innovation are becoming differentiators as environmental considerations influence purchasing decisions. Taken together, these shifts are creating an environment where agility, transparency, and cross-functional collaboration between R&D, regulatory, and commercial teams determine which brands can convert evolving consumer expectations into sustained preference.

Assessing how 2025 tariff adjustments altered sourcing choices, production footprint decisions, and supply chain resilience for throat pastilles manufacturers and distributors

Trade policy adjustments, including tariff changes enacted in 2025, introduced new complexities for manufacturers and distributors reliant on international ingredient sourcing and cross-border finished-goods flows. Increased import duties on certain inputs and packaging components raised landed costs for products that depend on raw materials from specific trading partners, prompting procurement teams to reassess supplier qualification, renegotiation strategies, and inventory policy. In several cases, manufacturers responded by accelerating localization of critical inputs or by shifting to alternate suppliers in jurisdictions with more favorable trade terms.

The tariff environment also affected decisions about production footprints. Companies with flexible manufacturing networks were able to reallocate production to plants in lower-cost or tariff-advantaged countries, thereby mitigating some tariff impact. Conversely, organizations with concentrated production experienced margin compression and were forced to prioritize high-margin SKUs, adjust pack sizes, or re-evaluate promotional investments. Distribution partners adapted by changing inventory buffers and revising pricing architectures to preserve retail competitiveness while maintaining distributor margins.

Beyond immediate cost implications, the tariff changes reinforced the importance of trade compliance capabilities and scenario planning. Risk-aware organizations invested in enhanced customs classification processes, deeper supplier audits, and hedging strategies for currency exposure associated with import activity. The cumulative effect of these measures improved supply chain resilience and informed longer-term strategic choices about supplier diversification and nearshoring versus global sourcing trade-offs.

Strategic segmentation insights that align actives, channels, product forms, flavors, pricing tiers, and age cohorts to optimize portfolio, messaging, and distribution approaches

Insightful segmentation is essential to understand consumer preferences and to align product and channel strategies. Based on Active Ingredient, the category encompasses formulations centered on eucalyptus, herbal blend, menthol, and zinc, each appealing to different consumer expectations around soothing, immunity support, or symptomatic relief; manufacturers should tailor claims, sensory profiles, and dosage presentation accordingly. Based on Distribution Channel, product performance varies widely across convenience stores, online retail, pharmacies & drugstores, and supermarkets & hypermarkets, with online retail favoring subscription and flavor innovation while pharmacies prioritize clinically framed messaging and shelf placement for trust-oriented purchases.

Product form drives usage occasion and acceptance, and based on Product Form, hard pastille, soft chewable, and sugar-free variants occupy distinct consumption contexts; hard pastilles often align with traditional throat-soothing rituals, soft chewables appeal to flavor-forward daily usage, and sugar-free options address dietary or health-conscious cohorts. Flavor preferences also map to usage and demographic patterns, and based on Flavor, lemon, mint, and mixed fruit are core profiles that enable brands to balance perceived efficacy with palatability; flavor pairing with active ingredient perception is especially influential in product trial and repeat purchase.

Pricing and positioning are equally pivotal and based on Price Tier, mid range, premium, and value tiers require differentiated packaging, ingredient transparency, and promotional tactics to resonate with cost-sensitive shoppers or premium buyers seeking functional benefits. Age segmentation informs both formulation and communication, and based on Consumer Age Group, adults, children, and seniors each demand tailored dosing cues, softer textures or chewability, milder flavors, and clearer labeling to ensure safety, compliance, and repeat usage patterns. Integrating these segmentation lenses supports targeted innovation, optimized channel strategies, and measured portfolio rationalization.

Comparative regional perspectives highlighting how consumer taste, regulatory nuance, retail structure, and manufacturing footprints shape throat pastilles strategies across global markets

Regional dynamics create distinct demand patterns and operational imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, consumer demand emphasizes convenience, flavor variety, and strong retail presence across pharmacy and supermarket channels, while e-commerce is rapidly supporting niche flavor and subscription-based offerings. In contrast, Europe, Middle East & Africa reflects a mosaic of regulatory environments and strong interest in natural ingredients and clinical credibility, which encourages brands to invest in harmonized labeling practices and regionally tailored ingredient sourcing.

Asia-Pacific exhibits dynamic growth in product innovation and local manufacturing capability, with consumer preferences often skewing toward gentle formulations, sweet profiles, and products that integrate traditional herbal ingredients. Across these regions, pricing sensitivity and retail structure vary considerably, requiring differentiated channel strategies and trade terms. Regulatory requirements also diverge: some markets emphasize pharmaceutical-style claims and packaging controls, while others are more permissive but increasingly attentive to quality assurance and import documentation.

Strategic entrants should prioritize region-specific go-to-market plans that reflect retail landscape, regulatory nuance, and consumer taste profiles. For multinational brands, balancing global brand consistency with local adaptation will be essential, and regional manufacturing footprints or partnerships can accelerate market entry while controlling landed cost and compliance risk.

How top players are balancing product innovation, omnichannel expansion, supply chain agility, and strategic partnerships to maintain leadership and adapt to evolving market pressures

Leading firms in the throat pastilles space are pursuing a combination of product innovation, channel diversification, and operational optimization to sustain competitive advantage. Investment in R&D is focused on formulations that combine trusted symptomatic actives with botanicals and sugar-free sweeteners to address both efficacy and daily wellness positioning. At the same time, manufacturers are optimizing packaging for clearer dosing guidance and improved shelf differentiation, and they are experimenting with multi-format launches to capture cross-occasion usage.

Commercially, companies are enhancing omnichannel capabilities by integrating digital marketing, e-commerce fulfillment, and pharmacy partnerships to extend reach and deepen consumer engagement. Private-label competition is rising in value-sensitive channels, prompting brand owners to double down on distinctive ingredient claims and evidence-based communication. On the supply side, firms are streamlining procurement, investing in dual-sourcing strategies, and expanding manufacturing agility to accommodate shifts in trade policy and ingredient availability.

Strategic collaborations and selective acquisitions are also prevalent, enabling rapid capability building in specialized ingredients, sustainable packaging, or regional distribution expertise. Companies that invest in analytical capabilities-consumer insights, SKU-level margin analysis, and trade compliance-are better positioned to respond to short-term disruptions while executing longer-term portfolio transformation.

Practical strategic actions for executives to accelerate product differentiation, strengthen distribution alignment, and fortify supply chain resilience while advancing sustainability goals

Industry leaders should adopt an integrated approach that couples consumer insight with operational flexibility to capitalize on category momentum. First, accelerate development of formulations that align with clean-label expectations and offer differentiated functional claims, ensuring that clinical or scientific evidence supports any efficacy statements. Pair these formulation advances with compelling sensory design-flavor and texture profiling-that reduces friction at trial and increases repeat purchase propensity.

Second, optimize channel strategies by aligning assortment to the purchase intent of each channel: design pharmacy-facing SKUs with clinical cues and clear dosing, curate online-exclusive bundles and subscription options, and retain high-visibility merchandising in supermarkets and convenience outlets to capture spontaneous demand. Strengthen digital capabilities to support targeted promotions and real-time inventory visibility.

Third, reinforce supply chain resilience by diversifying suppliers for critical inputs, evaluating nearshoring opportunities, and improving customs and trade compliance processes. Incorporate scenario planning for tariff and regulatory shifts and use flexible contract terms to manage cost volatility. Finally, invest in sustainability across packaging, ingredient sourcing, and carbon footprint reduction to meet growing consumer and procurement expectations. These actions should be sequenced with measurable KPIs tied to time-to-market, repeat purchase rates, and margin recovery to ensure disciplined execution.

A rigorous, mixed-methods research approach combining stakeholder interviews, retail observation, regulatory analysis, and data triangulation to ensure robust strategic guidance

This analysis synthesizes primary and secondary research methods to produce an evidence-based perspective. Primary research included structured interviews with category managers, procurement leads, retail buyers, and clinical experts to capture first-hand insights into formulation priorities, channel economics, and supply chain constraints. These interviews were supplemented by observational research at retail and e-commerce touchpoints to understand merchandising, product discoverability, and consumer review dynamics.

Secondary research drew on regulatory guidance, trade publications, and industry reporting to map policy shifts, ingredient approvals, and packaging standards that influence product design and market access. Data triangulation was applied to reconcile disparate inputs, validate qualitative observations against reported supply chain behaviors, and ensure that recommended actions are grounded in operational reality. Quality control measures included cross-validation by subject matter experts, consistency checks on sourcing claims, and a review of regulatory interpretations to avoid misleading positioning.

Limitations of the methodology are acknowledged: rapidly evolving regulations and episodic trade policy changes can alter the operating environment, and consumer preferences may shift in response to new scientific evidence or marketing innovations. To mitigate these constraints, the research incorporated scenario analysis and sensitivity checks to ensure robustness of strategic implications and recommendations.

Concluding synthesis that links consumer-driven formulation, channel alignment, and supply chain adaptability as the decisive levers for competitive advantage in the throat pastilles landscape

The collective analysis underscores that the throat pastilles category sits at the intersection of functional efficacy and everyday wellness behavior. Consumer demand for transparent ingredients, convenient formats, and credible health claims is driving product and channel innovation, while trade policy and regional regulatory nuance require adaptive sourcing and compliance strategies. Companies that align formulation, flavor, and form with clearly defined channel strategies will be better positioned to win trial and build loyalty across distinct consumer cohorts.

Operationally, supply chain agility and trade compliance are now core strategic enablers rather than mere cost centers. Firms that invest in dual sourcing, localized manufacturing options, and robust customs processes can mitigate tariff-driven volatility and sustain promotional activity without eroding margins. In parallel, a focus on sustainability and packaging innovation enhances brand differentiation and responds to investor and retailer expectations.

In summary, leadership in this category will come from organizations that integrate consumer insight, disciplined execution, and resilient operations. Those that move decisively to align product portfolios with channel economics and regional preferences will unlock durable advantages in an increasingly competitive and regulated environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Throat Pastilles Market, by Active Ingredient

  • 8.1. Eucalyptus
  • 8.2. Herbal Blend
  • 8.3. Menthol
  • 8.4. Zinc

9. Throat Pastilles Market, by Product Form

  • 9.1. Hard Pastille
  • 9.2. Soft Chewable
  • 9.3. Sugar Free

10. Throat Pastilles Market, by Flavor

  • 10.1. Lemon
  • 10.2. Mint
  • 10.3. Mixed Fruit

11. Throat Pastilles Market, by Price Tier

  • 11.1. Mid Range
  • 11.2. Premium
  • 11.3. Value

12. Throat Pastilles Market, by Consumer Age Group

  • 12.1. Adults
  • 12.2. Children
  • 12.3. Seniors

13. Throat Pastilles Market, by Distribution Channel

  • 13.1. Convenience Stores
  • 13.2. Online Retail
  • 13.3. Pharmacies & Drugstores
  • 13.4. Supermarkets & Hypermarkets

14. Throat Pastilles Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Throat Pastilles Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Throat Pastilles Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Throat Pastilles Market

18. China Throat Pastilles Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Bliss GVS Pharma Ltd
  • 19.6. Boiron SA
  • 19.7. Catalent, Inc. by Novo Holdings A/S
  • 19.8. Church & Dwight Co., Inc.
  • 19.9. Cipla Limited
  • 19.10. Dabur International Limited
  • 19.11. Doetsch Grether AG
  • 19.12. Essity AB (publ)
  • 19.13. Gepach International
  • 19.14. Haleon plc
  • 19.15. Kenvue Inc.
  • 19.16. Lofthouse of Fleetwood Ltd.
  • 19.17. Pfizer Inc.
  • 19.18. Prestige Consumer Healthcare Inc.
  • 19.19. Reckitt Benckiser Group plc
  • 19.20. Ricola AG
  • 19.21. Ricola Group AG
  • 19.22. Rohto Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THROAT PASTILLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THROAT PASTILLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL THROAT PASTILLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THROAT PASTILLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL THROAT PASTILLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES THROAT PASTILLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA THROAT PASTILLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL THROAT PASTILLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL THROAT PASTILLES MARKET SIZE, BY EUCALYPTUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL THROAT PASTILLES MARKET SIZE, BY EUCALYPTUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL THROAT PASTILLES MARKET SIZE, BY EUCALYPTUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL THROAT PASTILLES MARKET SIZE, BY HERBAL BLEND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL THROAT PASTILLES MARKET SIZE, BY HERBAL BLEND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL THROAT PASTILLES MARKET SIZE, BY HERBAL BLEND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL THROAT PASTILLES MARKET SIZE, BY MENTHOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL THROAT PASTILLES MARKET SIZE, BY MENTHOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL THROAT PASTILLES MARKET SIZE, BY MENTHOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL THROAT PASTILLES MARKET SIZE, BY ZINC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL THROAT PASTILLES MARKET SIZE, BY ZINC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL THROAT PASTILLES MARKET SIZE, BY ZINC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL THROAT PASTILLES MARKET SIZE, BY HARD PASTILLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL THROAT PASTILLES MARKET SIZE, BY HARD PASTILLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL THROAT PASTILLES MARKET SIZE, BY HARD PASTILLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL THROAT PASTILLES MARKET SIZE, BY SOFT CHEWABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL THROAT PASTILLES MARKET SIZE, BY SOFT CHEWABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL THROAT PASTILLES MARKET SIZE, BY SOFT CHEWABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL THROAT PASTILLES MARKET SIZE, BY SUGAR FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL THROAT PASTILLES MARKET SIZE, BY SUGAR FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL THROAT PASTILLES MARKET SIZE, BY SUGAR FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL THROAT PASTILLES MARKET SIZE, BY LEMON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL THROAT PASTILLES MARKET SIZE, BY LEMON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL THROAT PASTILLES MARKET SIZE, BY LEMON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL THROAT PASTILLES MARKET SIZE, BY MINT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL THROAT PASTILLES MARKET SIZE, BY MINT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL THROAT PASTILLES MARKET SIZE, BY MINT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL THROAT PASTILLES MARKET SIZE, BY MIXED FRUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL THROAT PASTILLES MARKET SIZE, BY MIXED FRUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL THROAT PASTILLES MARKET SIZE, BY MIXED FRUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL THROAT PASTILLES MARKET SIZE, BY MID RANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL THROAT PASTILLES MARKET SIZE, BY MID RANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL THROAT PASTILLES MARKET SIZE, BY MID RANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL THROAT PASTILLES MARKET SIZE, BY PREMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL THROAT PASTILLES MARKET SIZE, BY PREMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL THROAT PASTILLES MARKET SIZE, BY PREMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL THROAT PASTILLES MARKET SIZE, BY VALUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL THROAT PASTILLES MARKET SIZE, BY VALUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL THROAT PASTILLES MARKET SIZE, BY VALUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL THROAT PASTILLES MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL THROAT PASTILLES MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL THROAT PASTILLES MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL THROAT PASTILLES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL THROAT PASTILLES MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL THROAT PASTILLES MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL THROAT PASTILLES MARKET SIZE, BY SENIORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL THROAT PASTILLES MARKET SIZE, BY SENIORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL THROAT PASTILLES MARKET SIZE, BY SENIORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL THROAT PASTILLES MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL THROAT PASTILLES MARKET SIZE, BY CONVENIENCE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL THROAT PASTILLES MARKET SIZE, BY CONVENIENCE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL THROAT PASTILLES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL THROAT PASTILLES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL THROAT PASTILLES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL THROAT PASTILLES MARKET SIZE, BY PHARMACIES & DRUGSTORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL THROAT PASTILLES MARKET SIZE, BY PHARMACIES & DRUGSTORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL THROAT PASTILLES MARKET SIZE, BY PHARMACIES & DRUGSTORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL THROAT PASTILLES MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL THROAT PASTILLES MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL THROAT PASTILLES MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL THROAT PASTILLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS THROAT PASTILLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA THROAT PASTILLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL THROAT PASTILLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. GCC THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 135. GCC THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 136. GCC THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 137. GCC THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 138. GCC THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GCC THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. G7 THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 156. G7 THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 157. G7 THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 158. G7 THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 159. G7 THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. G7 THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. NATO THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 163. NATO THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 164. NATO THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 165. NATO THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 166. NATO THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. NATO THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL THROAT PASTILLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES THROAT PASTILLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA THROAT PASTILLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA THROAT PASTILLES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA THROAT PASTILLES MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA THROAT PASTILLES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA THROAT PASTILLES MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA THROAT PASTILLES MARKET SIZE, BY CONSUMER AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA THROAT PASTILLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)